683 Capital Management »

Transmedics Group shares owned by 683 Capital Management

Quarter-by-quarter ownership of Transmedics Group (TMDX) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Transmedics Group

Tip: Access up to 7 years of quarterly data

All positions including Transmedics Group held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Transmedics Group by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.4M 20k 121.65
2025-09-30 $2.2M 20k 112.20

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. Put Option (LLY)
Capital One Financial (COF)
Tesla Motors Put Option (TSLA)
NVIDIA Corporation Put Option (NVDA)
Wave Life Sciences SHS (WVE)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Alnylam Pharmaceuticals (ALNY)
Praxis Precision Medicines I Com New Put Option (PRAX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Protagonist Therapeutics (PTGX)
Gxo Logistics Incorporated Common Stock (GXO)
Hilton Grand Vacations (HGV)
Anaptysbio Inc Common (ANAB)

View all positions for 683 Capital Management

Top funds holding Transmedics Group

BlackRock
FMR
Vanguard Group
State Street Corporation
Ubs Global Asset Management Americas
Goldman Sachs Group
Geode Capital Management
Driehaus Capital Management
Citadel Advisors
Hood River Capital Management
Invesco
Susquehanna International
UBS Group
Two Sigma Investments
Eventide Asset Management

View all funds holding Transmedics Group